Capsigen

Capsigen is an adeno-associated virus (AAV) gene therapy company that engineers viral capsids that can deliver gene payloads to target cells while avoiding other tissues and organs, improving drug efficacy and reducing toxicity. Their platform screens billions of capsid candidates simultaneously and incorporates machin

Based, Capsigen works in advanced therapies.

Profile

Capsigen is an adeno-associated virus (AAV) gene therapy company that engineers viral capsids that can deliver gene payloads to target cells while avoiding other tissues and organs, improving drug efficacy and reducing toxicity. Their platform screens billions of capsid candidates simultaneously and incorporates machine learning and a rational design platform to generate capsids that are […]

The company sits in the advanced therapies segment, where it competes on its core product or service.

The company is listed at the Creative Destruction Lab alumni company stage of development.

Website: www.capsigen.com